Zum Inhalt wechseln

MEDIEN

FAQS

Wer ist Almirall?
HÄUFIG GESTELLTE FRAGEN

faqs
MEDIENKONTAKTE

Cohn & Wolfe
Tel: +34 91 531 50 97
Contact: Adriana Ibargüen

Almirall Media Relations
Tel: +34 93 291 30 00
Contact: Corporate Communications

Kontakt

Für Medien-Anfragen klicken Sie bitte auf den unten aufgeführten Link.

Kontakt

Neuigkeiten

24-03-2017

Almirall and Sun Pharma Announce Regulatory Filing of Tildrakizumab in Europe

Barcelona, SPAIN and Mumbai, INDIA, March 24, 2017: Almirall S.L, (Spanish Stock Exchange ticker: ALM, "Almirall") an ...

16-03-2017

Almirall and Symatese enter into a global strategic collaboration for the development and commercialization of products in the Aesthetics field

Almirall S.A., a global pharmaceutical company based in Barcelona, and Symatese, a leading developer and manufacturer ...

07-03-2017

Data from Tildrakizumab Clinical Development Program Presented at the 2017 American Academy of Dermatology Meeting

Barcelona, Spain, March 7, 2017 – Almirall S.L (Spanish Stock Exchange ticker: ALM) and Sun Pharmaceutical Industries Lt ...